CBUS vs CELU

Cibus, Inc. vs Celularity Inc. — Valuation Comparison 2026

CBUS

Biotechnology
Cibus, Inc.
Quality
5.7
out of 10
Value Trap
33
LOW
Price
$1.45
Last close
Models
8/13
Active
VS

CELU

Biotechnology
Celularity Inc.
Quality
4.9
out of 10
Value Trap
36
LOW
Price
$0.99
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType CBUS Fair ValueCBUS Upside CELU Fair ValueCELU Upside
Bayesian DCF Intrinsic $0.39 -73.0%
Earnings Power Value Intrinsic $3.41 +256.8%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $2.01 +38.7% $3.23 +225.9%
PWERM Option-Based $4.41 +204.2% $4.08 +311.8%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for CBUS vs CELU — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CBUS vs CELU — Which Stock Is More Undervalued?

CBUS scores higher with a 5.7/10 quality rating vs CELU's 4.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Cibus, Inc. (CBUS) and Celularity Inc. (CELU) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CBUS currently trades at $1.45 with a QOC of 5.7/10, while CELU trades at $0.99 with a QOC of 4.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).